What do our clients say about us? Read these testimonials to find out how Procertus Consulting has helped other businesses.

https://uk.linkedin.com/in/nicola-hewson-a575549

An investigation of the safety and pharmacokinetics of the novel TRPV1 antagonist XEN-D0501 in healthy subject

https://www.researchgate.net/publication/51221784_An_investigation of the safety and pharmacokinetics of the novel TRPV1 antagonist XEN-D0501 in healthy subject

Fulvestrant 500 mg Versus Anastrozole 1 mg for the First-Line Treatment of Advanced Breast Cancer: Overall Survival Analysis From the Phase II FIRST Study

https://www.researchgate.net/publication/282036951 Fulvestrant 500 mg_Versus Anastrozole 1_mg for the First-Line Treatment of Advanced Breast Cancer Overall Survival Analysis From the Phase II FIRST Study

Randomized Phase II trial of deferasirox (Exjade, ICL 670), a once-daily, orally administered iron chelation, in comparison to deferoxamine in thalassemia patients with transfused iron overload

https://www.researchgate.net/publication/6967194 Randomized Phase II trial of deferasirox Exjade ICL 670 a once-daily orally administered iron chelation in comparison to deferoxamine in thalassemia patients with transfused iron overload

Double-Blind, Placebo-Controlled, Randomized Phase III Trial of Darbepoetin Alfa in Lung Cancer Patients Receiving Chemotherapy

http://jnci.oxfordjournals.org/content/94/16/1211.full

Would you be willing to endorse Procertus Consulting Ltd?  Please contact us if you have feedback that you would like to pass on.  We appreciate all of your comments.

ProCertus Consulting can help you!  Need advice to set you on the right track?  Give us a call on:

01933 387468

Or fill out our contact form.

0900 - 1700 Mon - Fri

ProCertus Consulting Ltd

35 High Street

Higham Ferrers

Northamptonshire

NN10 8DD